Navigation Links
Perry Baromedical Announces New Cutting Edge Technology With Patient Data Capture Capability

RIVIERA BEACH, Fla., Dec. 14 /PRNewswire/ -- Perry Baromedical, international leader in Hyperbaric Chamber manufacturing for 40 years, announces the launch of the Sigma Elite, with extended patient data capture capability. The advanced technology of the Sigma Elite is available on each monoplace chamber model currently available ( and has a Patent Pending.

The Sigma Elite New "Smart Hyperbaric System" includes:

  • Data Capture Via Computerized System for Each Dive
  • Electronic (EMR) Medical Records Interface (Optional)
  • Individualized Patient Profiles
  • Visual Graphs in Real Time with Date & Time Log
  • Touch Screen Interface

According to Glenn Dennis, President/COO of Perry Baromedical, "the Sigma Elite now provides the ability for our chambers to provide Patient Data interface to EMR systems. This capability is unique and is in response to customer demand."

Standard features of the Sigma Elite Control and EMR System are:

  • Customizable Automated Treatment Protocols
  • Manual Treatments Captured for Future Use
  • Pneumatic Backup Control System
  • Analog Manual Set Point and Rate Set
  • Hard Copy of Treatment
  • Electronic Record of Treatment
  • Programmable Air Breath Alerts
  • Standard Treatment Profiles Pre-installed
  • Windows XPE Embedded Operating System
  • Split Screen Auxiliary Capability
  • Patient Record Dive Review

Perry Baromedical Corporation is dedicated to providing safe, cost effective and technologically advanced Hyperbaric Oxygen Chambers. Expertise and advanced technology along with proprietary manufacturing process and global resources, allow us to produce, ship, install and service the finest Hyperbaric Oxygen Chambers worldwide. Perry Baromedical is the only US hyperbaric chamber manufacturer that builds three acrylic monoplace models, dualplace, and multiplace units including the largest acrylic monoplace chamber in the world. or call 1-800-741-4376.

SOURCE Perry Baromedical

SOURCE Perry Baromedical
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
3. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
4. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
5. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
6. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
7. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
8. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
9. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
10. Genta Incorporated Announces Second Quarter 2007 Financial Results and Corporate Highlights
11. MicroDose Announces Positive Results From the QDose Inhaled Insulin Glucose Clamp Study
Post Your Comments:
(Date:11/25/2015)... , November 25, 2015 - Will ... Medical Education (CME) --> - Will ... Continuing Medical Education (CME) --> ... Continuing Medical Education (CME) ... products and services, will feature latest diagnostic imaging textbooks and decision ...
(Date:11/25/2015)... 25, 2015 Research and Markets ( ... Market - Global Forecast to 2020" report to ... accounting for 37.21% of the total market share in ... region is projected to growth at the highest ... attributed primarily to the fast growing water, industrial gas ...
(Date:11/25/2015)... --> --> ... für das Patent über eine neue Hepatitis-B-Behandlung, welches sie ... an Enyo Pharma vergeben haben. Im Rahmen ... und von Edelris gemeinsam mit seinen Partnern Inserm und ... HBV identifiziert, und es wurden neue Inhaltsstoffe entdeckt, die ...
Breaking Medicine Technology:
(Date:11/25/2015)... , ... November 25, 2015 , ... ... of philanthropic seniors, is resulting in a way for homeless people to have ... Schaumburg have launched a new initiative whereby they are repurposing plastic bags into ...
(Date:11/25/2015)... ... 2015 , ... Many people know of the common symptoms of low thyroid ... skin. But many people who find their cholesterol levels and weight are creeping up ... especially if they don’t have any of the other symptoms. , Thyroid hormone plays ...
(Date:11/25/2015)... , ... November 25, 2015 , ... ... Tuberous Sclerosis Complex (TSC), as well as raising public awareness of the disorder ... need it—presented a third donation of $35,000 to bolster progress at the Tuberous ...
(Date:11/25/2015)... ... ... Since its launch in 2012, the Regenestem brand ( ... to patients with chronic degenerative medical conditions. Now, the U.S. Patent and Trademark ... Organizations are required to hold a registered trademark in order to make licensing ...
(Date:11/25/2015)... ... November 25, 2015 , ... Students and parents have something to ... of the Create Real Impact awards. California Casualty is proud to support ... tide of distracted and reckless driving, the number one killer of young drivers. ...
Breaking Medicine News(10 mins):